A1-PINP Human Recombinant

• Description:

  A1-PINP Human Recombinant_x000D_ Catalog number: B2016392_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 ug_x000D_ Molecular Weight or Concentration: 15839 Da including C-terminal tag_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -80 °C_x000D_ Keywords: A1-PINP, human, recombinant_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Liu R, Chen L, Wu W, Chen H, Zhang S. Extracellular matrix turnover in coronary artery ectasia patients Heart Vessels. 2016 Mar;31(3):351-9._x000D_ 2: Andersen MB, Pingel J, Kjær M, Langberg H. Interleukin-6: a growth factor stimulating collagen synthesis in human tendon J Appl Physiol (1985). 2011 Jun;110(6):1549-54._x000D_ 3: Chen T, Li G, Xu Y. Study on the Effect of Bushen Zhuanggu Tablet Combined with Conventional Regimen on Bone Mineral Density Improvement, Functional Recovery and Fracture Risk Prevention in Patients with Postmenopausal Osteoporosis Comput Math Methods Med. 2023 Jul 7;2023:4846392._x000D_ 4: Cosman F, Eriksen EF, Recknor C, Miller PD, Guañabens N, Kasperk C, Papanastasiou P, Readie A, Rao H, Gasser JA, Bucci-Rechtweg C, Boonen S. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis J Bone Miner Res. 2011 Mar;26(3):503-11._x000D_ 5: Moreira LD, Fronza FC, Dos Santos RN, Zach PL, Kunii IS, Hayashi LF, Teixeira LR, Kruel LF, Castro ML. The benefits of a high-intensity aquatic exercise program (HydrOS) for bone metabolism and bone mass of postmenopausal women J Bone Miner Metab. 2014 Jul;32(4):411-9._x000D_ 6: Peris P, Alvarez L, Monegal A, Guañabens N, Durán M, Pons F, Martínez de Osaba MJ, Echevarría M, Ballesta AM, Muñoz-Gómez J. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy Bone. 1999 Sep;25(3):349-53._x000D_ 7: Alvarez L, RicOs C, Peris P, GuaNabens N, Monegal A, Pons F, Ballesta AM. Components of biological variation of biochemical markers of bone turnover in Paget's bone disease Bone. 2000 Jun;26(6):571-6._x000D_ 8: Hitz MF, Jensen JE, Eskildsen PC. Bone mineral density and bone markers in patients with a recent low-energy fracture: effect of 1 y of treatment with calcium and vitamin D Am J Clin Nutr. 2007 Jul;86(1):251-9._x000D_ 9: Sajanti J, Majamaa K. Detection of meningeal fibrosis after subarachnoid haemorrhage by assaying procollagen propeptides in cerebrospinal fluid J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):185-8._x000D_ 10: Haapasaari KM, Raudaskoski T, Kallioinen M, Suvanto-Luukkonen E, Kauppila A, Läärä E, Risteli J, Oikarinen A. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women Maturitas. 1997 Jun;27(2):153-62. _x000D_ _x000D_ Products Related to A1-PINP Human Recombinant can be found at Proteins

• Short Description:

  Catalog Number: B2016392 (50 ug)_x000D_ A1-PINP Human Recombinant is a high quality procollagen type I N-terminal propeptide produced using recombinant DNA technology. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5

• CAS Number:

  9000-83-3